Author

Bengt Kull

AstraZeneca (Sweden)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Anita SalamoniD· 1 shared Erik MichaëlssoniD· 1 shared Gabriel F. AlencariD· 1 shared Gary K. OwensiD· 1 shared Heather DoviakiD· 1 shared Kenneth X. WalshiD· 1 shared Laura S. ShankmaniD· 1 shared Marie PerssoniD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPhysiology

Anita SalamonORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

PhysiologyCirculationPeer-reviewedJun 17, 2024

Mouse Model of Heart Attack and Stroke Shows Improved Survival with MPO Inhibition

Sohel Shamsuzzaman, Rebecca A. Deaton, Anita Salamon…·Gary K. Owens

The paper introduces a mouse model of advanced atherosclerosis that exhibits spontaneous plaque rupture leading to MI or stroke, and shows that MPO inhibition with AZM198 reduces mortality and plaque rupture incidence.

62 citationstop 1%

mouseexperimental assay

𝕏 PostBluesky